Skip to main content

Table 3 Utility, DALY, and economic comparisons between CRS, asthma and DM

From: Chronic rhinosinusitis: an under-researched epidemic

Chronic disease Health state utility (SF-6D derived) Disability weight Annual direct health care cost Annual indirect cost
CRS 0.65 [9] Not defined $3,143/patient [23] a$10,500/patient [10]
Asthma 0.70 [19] b0.009 [24] $4,081/patient [25] d$5,846/patient [25]
c0.027 [24]
DM 0.68 [20] 0.015 [26] $7,900/patient [27] $3,920/patient [27]
  1. (Note: all values were adjusted with an inflation calculator to reflect 2014 USD).
  2. DALY, disability adjusted life years; CRS, chronic rhinosinusitis; DM, diabetes mellitus; SF, short-form.
  3. aThis indirect cost reflects patients with refractory CRS who were recruited from a tertiary level centre and likely over-estimates the mean indirect cost for all patients with CRS.
  4. bThis is the disability weight for ‘controlled asthma’.
  5. cThis is the disability weight for ‘partially controlled asthma’.
  6. dThis indirect cost reflects patients with severe asthma and likely overestimates the mean indirect cost for all patients with asthma.